Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
06/2003
06/19/2003CA2469204A1 Prospective identification and characterization of breast cancer stem cells
06/19/2003CA2468785A1 Beverage treated with nicotine
06/19/2003CA2468335A1 Chondrocyte precursors derived from human embryonic stem cells
06/18/2003EP1319708A2 Human recombinant cell for bone or cartilage cell binding
06/18/2003EP1319684A1 The preparation method of a stable polymer aqueous phase-aqueous phase emulsion and its use
06/18/2003EP1319410A1 Use of micro-organisms for a directed delivery of substances to specific parts of the gut
06/18/2003EP1319407A1 Pharmaceutical composition for topical treatment of skin disorders and skin wounds
06/18/2003EP1319345A1 The effect of a buffering agent on acidogenesis of plaque
06/18/2003EP1319082A2 Expression vectors containing hybrid ubiquitin promoters
06/18/2003EP1319069A2 Compositions and methods for the therapy and diagnosis of lung cancer
06/18/2003EP1319066A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
06/18/2003EP1319064A2 Gsk3 polypeptides
06/18/2003EP1319023A2 An hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof
06/18/2003EP1318833A2 Compositions and methods for cell dedifferentiation and tissue regeneration
06/18/2003EP1318823A1 Immunomodulatory preparation
06/18/2003EP1318822A1 Cell implantation therapy for neurological diseases or disorders
06/18/2003EP1318810A1 Manzamines for treatment of drug resistant infection
06/18/2003EP1318725A2 Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
06/18/2003EP1171578B1 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
06/18/2003EP1171128B1 Combination of n-butyldeoxynojirimycin (nb-dnj) and glycolipid degrading enzymes in therapy
06/18/2003EP1021414B1 Frangible compounds for pathogen inactivation
06/18/2003EP0936902B1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
06/18/2003EP0821739B1 An adenovirus helper-virus system
06/18/2003EP0727938B1 Device and method for photoactivation
06/18/2003EP0650377B1 Neuroinhibitory compounds released by implanting devices
06/18/2003CN1425073A 病毒株 Strains
06/18/2003CN1425072A Gene therapy of HIV-positive patients by the expression of membrane-anchored gp41 peptides
06/18/2003CN1425065A Method of controlling telomere length
06/18/2003CN1425061A Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
06/18/2003CN1425024A Haemostatically active preparation containing VWF and production thereof
06/18/2003CN1424870A Nuclear transfer with selected donor cells
06/18/2003CN1424108A Defatted rana amurensis ovary powder for women healthy food
06/18/2003CN1424106A Medicines for treating depression and preparation thereof
06/18/2003CN1424103A Chinese medicine for sub-health and its preparing method
06/18/2003CN1424098A Medicines for treating pulmonary tuberculosis
06/18/2003CN1424097A Medicines for treating cervical vertebra illness
06/18/2003CN1424072A Healthy fermentative wine preparation
06/18/2003CN1424071A Auxiliary medicine for treating esophagus cancer and processing method thereof
06/18/2003CN1424070A Plaster
06/18/2003CN1424067A Medicines for treating cancers and tumours
06/18/2003CN1424065A Medicine for nasal obstruction
06/18/2003CN1424064A Healthy medicinal spirit for tonifying kidney and strengthening Yang
06/18/2003CN1424062A Chinese medicine for gastrointestinal cancers and its preparation
06/18/2003CN1424054A Bacterial Chinese medical preparation and preparing method thereof
06/18/2003CN1424053A Capsule agent of chanhua mycelia and preparing method thereof
06/18/2003CN1424052A Medicine for treating chronic hepatitis B
06/18/2003CN1424051A Lyophilized scorpion venoms powder injection
06/18/2003CN1424050A Capsules of rana amurensis ovary
06/18/2003CN1424049A Oral medicine for mastadenitis and mammary pains and preparing method thereof
06/18/2003CN1111426C Diabetes treating medicine
06/18/2003CN1111425C Plaster for treating hyperosteogeny
06/18/2003CN1111424C Ginseng astragalus capsule for curing hemiplegia
06/18/2003CN1111423C Medicine for treating injury
06/18/2003CN1111422C Injection for treating piles and its preparing process
06/18/2003CN1111421C Natural drug-dropping medicine
06/18/2003CN1111419C Medicine for treating cardiovascular and cerebrovascular apoplexy and applexy aurae and its preparing process
06/18/2003CN1111416C Insomnic plaster
06/18/2003CN1111415C Medicine for hyperosteogeny and protrusion of intervertebral disc
06/17/2003US6579973 Compositions for the treatment and diagnosis of breast cancer and methods for their use
06/17/2003US6579855 Adenovirus-mediated gene therapy
06/17/2003US6579711 Lactic acid bacteria species
06/17/2003US6579683 A ligand which is a member of Ephrin family of Eph family receptor interactive protein has been shown to be expressed by arterial endothelial cells but not by venous endothelial cell, useful for distinguishing target artieris and veins
06/17/2003US6579526 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/17/2003US6579523 Transplants for myocardial scars
06/17/2003US6579522 Replication deficient adenoviral TNF vector
06/17/2003US6579313 Methods for implanting cells
06/17/2003CA2183472C Liquid paraffin oil and lactulose-based hypocaloric laxative jelly and method for its preparation
06/17/2003CA2141803C Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
06/17/2003CA2118816C Composition for introducing nucleic acid complexes into higher eucaryotic cells
06/12/2003WO2003048780A2 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
06/12/2003WO2003048423A1 Contact assemblies for electrochemical processing of microelectronic workpieces and method of making thereof
06/12/2003WO2003048347A1 Periosteal distraction
06/12/2003WO2003048344A2 Differentiation of human embryonic stem cells in avian embryos
06/12/2003WO2003048338A2 Nucleic acid injected into hepatic vein lumen and delivered to primate liver
06/12/2003WO2003048336A2 Cultured cells from pancreatic islets
06/12/2003WO2003048209A1 Bispecific anti-cd19 x anti-cd16 antibodies and uses thereof
06/12/2003WO2003048205A2 Novel proteins with il-6 inhibiting activity
06/12/2003WO2003048184A2 Flavivirus ns1 subunit vaccine
06/12/2003WO2003048183A2 Method for obtaining oestrogen from mare urine
06/12/2003WO2003047647A1 Method for forming matrices of hardened material
06/12/2003WO2003047635A1 Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders
06/12/2003WO2003047617A2 Vaccine
06/12/2003WO2003047616A1 Migration of hematopoietic stem cells and progenitor cells to th e liver
06/12/2003WO2003047607A1 Medicinal compositions containing human amnion-origin cells
06/12/2003WO2003047606A2 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors
06/12/2003WO2003047596A2 Ointment for soothing dermatitis
06/12/2003WO2003047589A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
06/12/2003WO2003047533A2 Composition for treating the surface of the skin
06/12/2003WO2003047506A2 Peptide agonists of prostate-specific antigen, and uses therefor
06/12/2003WO2003047353A1 Probiotic formulation and method for reduction of pathogenic bacteria
06/12/2003WO2003018752A3 An organotypic intestinal culture and methods of use thereof
06/12/2003WO2002068627A3 Vector constucts
06/12/2003WO2002008389A9 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
06/12/2003WO2001071007A3 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF
06/12/2003US20030110524 Transgenic organisms and their uses
06/12/2003US20030109849 Catheter for cell delivery in tissue
06/12/2003US20030109465 TGF- beta blocking agent-treated HSC compositions and methods comprising the same. The TGF- beta blocking agent-treated stem cells are viable for an extended time in culture without replication or differentiation and upon transfer to conditions
06/12/2003US20030109041 Culture regeneration of nervous systems; cell differentiation; wound healing agent
06/12/2003US20030109039 Enriched central nervous system stem cell and porgenitor cell populations, and methods for identifying, isolating and enriching for such populations
06/12/2003US20030109038 Chondrocyte precursors derived from human embryonic stem cells
1 ... 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 ... 1259